Gilde Healthcare Partners overview
Stories about Gilde Healthcare Partners
Gilde Healthcare closes Fund III on €145m
The Dutch firm, which had a re-up rate of above 80%, will continue to target deals on both sides of the Atlantic.
Gilde Healthcare Partners closes €150m European venture fund(4)
Gilde’s latest healthcare fund more than doubles assets under management, while continuing to target early stage deals.
Gilde Healthcare Partners closes €150m European venture fund(3)
Gilde’s latest healthcare fund more than doubles assets under management, while continuing to target early stage deals.
Gilde Healthcare Partners closes €150m European venture fund(2)
Gilde’s latest healthcare fund more than doubles assets under management, while continuing to target early stage deals.
Gilde Healthcare Partners closes €150m European venture fund
Gilde’s latest healthcare fund more than doubles assets under management, while continuing to target early stage deals.
Gilde Healthcare Partners contact information
Offices
Contacts
| Name | Job title | Location | |
|---|---|---|---|
| Key Contact | Job titleChief Financial Officer and Risk Officer | LocationUtrecht, Netherlands | Email |
| Key Contact | Job titlePartner & Head of Investor Relations | LocationUtrecht, Netherlands | Email |
Job titleCo-Founder and Managing Partner | LocationUtrecht, Netherlands | Email | |
Job titleManaging Partner | LocationUtrecht, Netherlands | Email | |
Gilde Healthcare Partners funds managed
Funds in market: 2
| Fund | Fund size | Open date | Strategy |
|---|---|---|---|
Fund size | Open date- | Strategy | |
Fund size | Open date- | Strategy | |
Closed funds: 10
| Fund | Fund size | Close date | Strategy |
|---|---|---|---|
Fund size | Close dateNov 2023 | Strategy | |
Fund size | Close dateMar 2022 | Strategy | |
Fund size | Close dateMar 2020 | Strategy | |
Stories that mention Gilde Healthcare Partners
Side Letter: Future Fund's Carlyle hire; China's buyout boom; BlackRock's LP survey
Australia's sovereign wealth fund has tapped a former Carlyle boss to lead its private equity programme. Plus: Why buyouts could boom in China; and results from BlackRock's inaugural private markets survey. Here’s today's brief, for our valued subscribers only.
UK's 'ambiguous' takeover rules could stifle healthcare deals
The rules, which came into force on 23 June, will enable the UK government to intervene in foreign takeovers of British companies deemed critical in public health emergencies.
Covid-19: GPs face heightened EU scrutiny on healthcare assets
Foreign PE firms looking to acquire healthcare-related companies in Europe can expect another three months of FDI review added to the deal process.
Advent bets on attractive healthcare sector
Advent International is trying to complete its third healthcare deal of the year in the sector that has proven attractive to firms as an area of stability in the sluggish economy.
Gilde finds anchor investor for €200m fund
Gilde senior partner Pieter van der Meer hopes to hold a first close on its third healthcare-focused fund this year.
KBC and SR One lead €40m Ablynx financing
KBC Private Equity, a Belgian private equity firm, has made its second investment in a Belgian biotechnology firm this week by leading a €40m Series financing for Ablynx, which develops protein products for serious diseases including Alzheimer’s.